XML 76 R39.htm IDEA: XBRL DOCUMENT v3.20.1
Business and Basis of Presentation (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 12, 2020
shares
$ / shares
Feb. 11, 2020
shares
Feb. 29, 2020
USD ($)
shares
Mar. 31, 2020
USD ($)
segment
shares
Mar. 31, 2019
USD ($)
shares
Dec. 31, 2019
USD ($)
Rate
shares
Dec. 31, 2018
USD ($)
shares
Mar. 31, 2018
shares
Mar. 26, 2018
shares
Feb. 28, 2018
shares
Dec. 31, 2017
shares
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Convertible preferred stock, authorized (in shares)           31,850,304          
Convertible preferred stock, shares issued (in shares)           31,850,304 31,850,304        
Convertible preferred stock, shares outstanding (in shares)           31,850,304          
Common stock, shares authorized (in shares)     750,000,000 750,000,000   29,012,034 29,012,034 29,012,034   24,867,458  
Common stock, shares issued (in shares) 4,171,571 50,325,662   35,135,520   4,220,998 4,219,606        
Common stock outstanding (in shares) 4,171,571 50,325,662   35,135,520   4,220,998 4,219,606        
Conversion rate for options and warrants | Rate           1206.3959%          
Merger conversion rate (in shares) 0.08289152527                    
Common stock, forfeited and cancelled (in shares)   682,699                  
Shares issued under company plans (in shares) 2,461,923     2,458,091 2,371,545 2,473,130 2,377,180       2,435,837
Number of shares (in shares) 15,461 186,535   15,461   15,461          
Conversion price per share on convertible note payable (in dollars per share) | $ / shares $ 5.12                    
Maximum number of shares of common stock issuable (in shares) 3,076,171                    
Proceeds from issuance of common stock, net of offering cost | $     $ 19,700,000 $ 19,741,000 $ 0            
Goodwill impairment charges | $       0 0 $ 0          
Impairment of intangible assets | $       0 0 $ 0 $ 0        
Grant reimbursement | $       $ 72,000 $ 0            
Award vesting period       4 years              
Number of anti-dilutive shares (in shares)       2,473,552 2,397,702 26,422,608 26,337,286        
Number of reportable segments | segment       1              
Revenue, net | $       $ 1,100,000 $ 529,000 $ 11,934,000 $ 1,358,000        
Cash and cash equivalents | $       $ 14,648,000   $ 2,875,000 $ 3,069,000        
Series 1 Preferred Stock                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Convertible preferred stock, authorized (in shares)       0   12,438,704 12,438,704        
Convertible preferred stock, shares issued (in shares)   51,680,254   0   12,433,953 12,433,953        
Convertible preferred stock, shares outstanding (in shares)   51,680,254   0   12,433,953 12,433,953        
Common stock outstanding (in shares) 12,433,953                    
Series 2 Preferred Stock                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Convertible preferred stock, authorized (in shares)       0   7,507,699 7,507,699        
Convertible preferred stock, shares issued (in shares)   38,760,190   0   7,499,996 7,499,996        
Convertible preferred stock, shares outstanding (in shares)   38,760,190   0   7,499,996 7,499,996        
Common stock, shares issued (in shares) 7,499,996                    
Common stock outstanding (in shares) 7,499,996                    
Series 3 Preferred Stock                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Convertible preferred stock, authorized (in shares)       0   4,000,000 4,000,000        
Convertible preferred stock, shares issued (in shares)   31,850,304   0   4,000,000 4,000,000   4,000,000    
Convertible preferred stock, shares outstanding (in shares)   31,850,304   0   4,000,000 4,000,000        
Common stock, shares issued (in shares) 4,000,000                    
Common stock outstanding (in shares) 4,000,000                    
Previously Reported                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Common stock, shares authorized (in shares)           350,000,000 350,000,000        
Common stock, shares issued (in shares)           50,921,951 50,905,160        
Common stock outstanding (in shares)           50,921,951 50,905,160        
Shares issued under company plans (in shares)           2,473,198          
Previously Reported | Series 1 Preferred Stock                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Convertible preferred stock, authorized (in shares)           51,700,000 51,700,000        
Convertible preferred stock, shares issued (in shares)           51,680,254 51,680,254        
Convertible preferred stock, shares outstanding (in shares)           51,680,254 51,680,254        
Previously Reported | Series 2 Preferred Stock                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Convertible preferred stock, authorized (in shares)           38,800,000 38,800,000        
Convertible preferred stock, shares issued (in shares)           38,760,190 38,760,190        
Convertible preferred stock, shares outstanding (in shares)           38,760,190 38,760,190        
Previously Reported | Series 3 Preferred Stock                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Convertible preferred stock, authorized (in shares)             31,850,304        
Convertible preferred stock, shares outstanding (in shares)             31,850,304        
Stock options                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Number of anti-dilutive shares (in shares)       2,458,091 2,371,545 2,473,198 2,377,180        
Warrant                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Number of anti-dilutive shares (in shares)       15,461 26,157 15,461 26,157        
Minimum                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Property and equipment, estimated useful life       3 years   3 years          
Estimated useful life (in years)       3 years 10 years 3 years          
Maximum                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Property and equipment, estimated useful life       7 years   7 years          
Estimated useful life (in years)           10 years          
JAPAN                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Percentage of cash and cash equivalents in foreign subsidiary       0.20%   1.90% 8.60%        
Revenue, net | $       $ 11,000 $ 7,000 $ 28,000 $ 49,000        
Cash and cash equivalents | $       31,000   55,000 264,000        
UNITED STATES                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Revenue, net | $       1,100,000 $ 522,000 11,900,000 1,300,000        
Other Assets                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Cash included in other assets | $       75,000   75,000 75,000        
Yaskawa Note                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Maximum number of shares of common stock issuable (in shares) 3,076,171                    
Long-term loan facility | $       15,000,000.0              
Accrued interest on promissory note | $       $ 373,000   $ 336,000 $ 186,000        
Transphorm Technology 2007 Stock Plan and 2015 Equity Incentive Plan                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Shares issued under company plans (in shares)   29,703,285                  
The 2020 Equity Incentive Plan                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Shares issued under company plans (in shares)       0              
Series 1 Preferred Stock                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Convertible preferred stock, shares issued (in shares)   51,680,254                  
Convertible preferred stock, shares outstanding (in shares)   51,680,254                  
Share conversion in connection with the Merger (in shares) 12,433,953                    
Series 2 Preferred Stock                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Convertible preferred stock, shares issued (in shares)   38,760,190                  
Convertible preferred stock, shares outstanding (in shares)   38,760,190                  
Conversion of stock (in shares) 7,499,996                    
Series 3 Preferred Stock                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Convertible preferred stock, shares issued (in shares)   31,850,304                  
Conversion of stock (in shares) 4,000,000                    
Common Stock                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Common stock outstanding (in shares)       35,135,520 4,219,606 4,220,998 4,219,606       4,219,606
Price per share (in dollars per share) | $ / shares $ 4.00                    
Share conversion in connection with the Merger (in shares)       23,933,949              
Transphorm Technology                      
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                      
Share conversion in connection with the Merger (in shares) 28,105,520